Transport of solutes across polar epithelia is required for function of many organs, e.g., kidney. In turn, epithelial transport depends upon the coordinated function of transport proteins in apical and basal poles of these cells. In recent years, we have examined the mechanism and energetics of renal organic anion (OA) transport, the major system which governs the elimination of foreign chemicals, demonstrating its indirect coupling to metabolic energy through Na/alpha-ketoglutarate (alphaKG) co- transport and OA/alphaKG exchange. Our current focus is on the intracellular and luminal events associated with OA transport, the mechanism(s) of OA transport in extrarenal tissues, and the molecular biology of the OA system. Isolated luminal membrane vesicles show both anion exchange and carrier-mediated, potential-driven pathways. However, only the potential-driven pathway appears to mediate luminal exit of secreted OA. Interestingly, during secretion OA show punctate accumulation within the cytoplasm. This process is energy dependent and saturable. Its relation to net transport is under investigation. Extrarenal tissues (liver and choroid plexus) also appear to utilize indirect Na coupling to drive OA transport. However, this appears to be substrate specific, e.g., fluorescein, but not 2,4-dichlorophenoxyacetic acid, in the choroid plexus and taurocholate, but not bile pigments, in the liver, show Na/alphaOG coupled transport. The basis for these differences is under study. Finally, initial steps in expression cloning of the renal OA transport proteins have been completed and a cDNA library is currently being screened to identify clones which carry nucleotides encoding these transport proteins. Once isolated these nucleotides will provide probes for investigation of the control, development, and distribution of this important excretory transport system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES080031-16
Application #
3841156
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
1992
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Srimaroeng, Chutima; Cecile, Jennifer Perry; Walden, Ramsey et al. (2013) Regulation of renal organic anion transporter 3 (SLC22A8) expression and function by the integrity of lipid raft domains and their associated cytoskeleton. Cell Physiol Biochem 31:565-78
Barros, Scott A; Srimaroeng, Chutima; Perry, Jennifer L et al. (2009) Activation of protein kinase Czeta increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated transport. J Biol Chem 284:2672-9
Srimaroeng, C; Perry, J L; Pritchard, J B (2008) Physiology, structure, and regulation of the cloned organic anion transporters. Xenobiotica 38:889-935
Bow, Daniel A J; Perry, Jennifer L; Miller, David S et al. (2008) Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes. Drug Metab Dispos 36:198-202
Kimura, T; Perry, J; Anzai, N et al. (2007) Development and characterization of immobilized human organic anion transporter-based liquid chromatographic stationary phase: hOAT1 and hOAT2. J Chromatogr B Analyt Technol Biomed Life Sci 859:267-71
Aslamkhan, Amy G; Thompson, Deborah M; Perry, Jennifer L et al. (2006) The flounder organic anion transporter fOat has sequence, function, and substrate specificity similarity to both mammalian Oat1 and Oat3. Am J Physiol Regul Integr Comp Physiol 291:R1773-80
Bow, Daniel A J; Perry, Jennifer L; Simon, John D et al. (2006) The impact of plasma protein binding on the renal transport of organic anions. J Pharmacol Exp Ther 316:349-55
Perry, Jennifer L; Dembla-Rajpal, Neetu; Hall, Laura A et al. (2006) A three-dimensional model of human organic anion transporter 1: aromatic amino acids required for substrate transport. J Biol Chem 281:38071-9
Srimaroeng, Chutima; Chatsudthipong, Varanuj; Aslamkhan, Amy G et al. (2005) Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8). J Pharmacol Exp Ther 313:621-8
Pritchard, John B; Miller, David S (2005) Expression systems for cloned xenobiotic transporters. Toxicol Appl Pharmacol 204:256-62

Showing the most recent 10 out of 31 publications